Xvivo Perfusion Logo

Xvivo Perfusion

Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.

XVIVO | ST

Overview

Corporate Details

ISIN(s):
SE0004840718 (+1 more)
LEI:
549300G2464FYLS14B41
Country:
Sweden
Address:
Gemenskapens Gata 9, 431 53 Mölndal
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Xvivo Perfusion is a medical technology company specializing in solutions for ex-vivo organ preservation. The company develops and markets innovative systems, solutions, and services that enable clinicians and researchers to preserve, assess, and transport donated organs—including lungs, hearts, livers, and kidneys—outside the body prior to transplantation. Its core offering is centered on machine perfusion technology, which aims to increase the availability and improve the quality of viable organs. Key products include the XPS™ (Ex Vivo Lung Perfusion System), Liver Assist™, and Kidney Assist Transport™, as well as the PERFADEX® Plus preservation solution. Xvivo's technologies are designed to extend organ preservation time, enhance assessment, and ultimately improve transplant outcomes, addressing the global shortage of transplantable organs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 10:01
Major Shareholding Notification
Swedish 9.5 KB
2025-07-28 22:10
Legal Proceedings Report
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
Swedish 64.3 KB
2025-07-28 22:10
Legal Proceedings Report
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
English 63.6 KB
2025-07-11 07:30
Interim Report
Swedish 2.0 MB
2025-07-11 07:30
Interim Report
English 2.0 MB
2025-04-25 14:25
Post-Annual General Meeting Information
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Swedish 59.6 KB
2025-04-25 14:25
Post-Annual General Meeting Information
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
English 60.1 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.9 MB
2025-04-24 07:30
Interim Report
English 6.8 MB
2025-03-20 17:45
Pre-Annual General Meeting Information
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
English 111.0 KB
2025-03-20 17:45
Pre-Annual General Meeting Information
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
Swedish 108.6 KB
2025-01-28 07:30
Earnings Release
Swedish 1.2 MB
2025-01-28 07:30
Annual / Quarterly Financial Statement
English 1.2 MB
2024-12-02 10:46
Major Shareholding Notification
Swedish 8.3 KB
2024-10-24 07:30
Quarterly Report
Swedish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-28 Lena Hagman Other Buy 1,500 466,500.00 SEK
2024-11-25 Christoffer Björn Rosenblad Other Sell 2,000 915,000.00 SEK
2024-02-29 Kristoffer Nordström Other Buy 335 88,440.00 SEK
2023-11-14 Gösta Johannesson Other Buy 500 124,500.00 SEK
2023-04-24 Lars Henriksson Other Buy 400 107,200.00 SEK
2022-11-02 Gösta Johannesson Other Buy 200 34,000.00 SEK
2022-11-01 Gösta Johannesson Other Buy 1,000 166,500.00 SEK
2022-08-19 Dag Andersson Tilk Other Buy 499 99,700.20 SEK
2022-05-24 Dag Andersson Tilk Other Other 5,417 1,115,251.96 SEK
2022-05-24 Christoffer Björn Rosenblad Other Other 2,708 557,523.04 SEK

Peer Companies

Company Country Ticker View
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea 314930
Biohit Oyj Logo
Develops diagnostic tests and lab systems for healthcare, research, and industrial laboratories.
Finland BIOBV
BIONEERCORPORATION Logo
Provides molecular biology tools & diagnostic kits for research and clinical applications.
South Korea 064550
BioNote, Inc. Logo
Manufactures veterinary diagnostics, analyzers, and software for animal health professionals.
South Korea 377740
Develops & manufactures HA-based biomaterials & medical devices for aesthetics & medical sectors.
South Korea 099430
Bioretec Oy Logo
Develops bioabsorbable orthopedic implants for adults & children, eliminating removal surgery.
Finland BRETEC
Boditech Med Inc. Logo
Develops & manufactures rapid point-of-care in-vitro diagnostic solutions for medical pros.
South Korea 206640
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium MLBON
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden BOUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.